Braveheart Bio, Inc. (BRVE)
29.20
+1.49
(+5.38%)
USD |
NASDAQ |
Sep 18, 16:00
28.95
-0.25
(-0.86%)
After-Hours: 20:00
Braveheart Bio Total Assets (Quarterly) : 126.96M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 126.96M |
| Date | Value |
|---|---|
| March 31, 2026 | 81.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 87.63B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| IGC Pharma, Inc. | 9.496M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.342M |
| Shareholders Equity (Quarterly) | 117.61M |
| Debt to Equity Ratio | 0.0049 |
| Current Ratio | 13.63 |